This bill, the "Stop Pills That Kill Act," would change the Controlled Substances Act to cover fentanyl, analogues of fentanyl, and "counterfeit fentanyl or methamphetamine substances." The bill defines a counterfeit substance as one that contains fentanyl, an analogue of fentanyl, or methamphetamine and that is marketed or sold using the name, mark, or imprint of another product. It inserts fentanyl and counterfeit substances into an existing list of prohibited acts. The bill also requires the Drug Enforcement Administration (DEA) to create an operation and response plan within 180 days. That plan must include strategies for federal investigations and seizures, ways to increase education and prevention (including tailoring efforts to youth and reviewing programs such as Operation Engage), and an audit of current campaigns like the "One Pill Can Kill" campaign. The Attorney General, working with the DEA and the Office of National Drug Control Policy, must send Congress an annual report with data on seizures, pill-form breakdowns, substances found in pills, locations and times of seizures, charges filed and convictions, and prevention measures.
No publicly available information on authorized funding, estimated costs, or appropriations is included in the bill text or metadata.
The bill text and sponsors (Sen. Chuck Grassley, Sen. Maggie Hassan, and Sen. Angus King) signal an intent to expand criminal coverage to fentanyl and counterfeit pills, strengthen federal enforcement tools, increase prevention and education efforts (especially for youth), and provide Congress with annual data on seizures and prosecutions.
No publicly available information on opponents' views or official objections appears in the bill text or the provided metadata.